KIROMIC BIOPHARMA INC (KRBP)

US4976342042 - Common Stock

1.45  -0.13 (-8.23%)

After market: 0.6931 -0.76 (-52.2%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
24.39M31.12M25.31M19.20M3.71M
Research and Development
10.98M13.45M11.37M5.05M1.20M
Selling, General, and Administrative Expenses
13.41M17.67M13.94M14.14M2.50M
Operating Income
-24.39M-31.12M-25.31M-19.20M-3.71M
Interest Income/Expense
-940.00K-170.00K-10.00K0.00-20.00K
Other Income/Expense
-450.00K0.0050.00KN/AN/A
Non Recurring Items
N/A-3.46M-320.00KN/AN/A
Income Before Taxes
-30.99M-34.73M-25.59M-19.20M-3.73M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-31.86M-35.08M-25.81M-19.91M-3.73M
EBITDA
-22.19M-29.45M-24.84M-19.00M-3.62M
 
Per Share Data
EPS Diluted Total Ops
-47.46-64.96-67.92-82.95-15.54
 
Statistics

All data in USD

Charts